IL1B and neoplasm: These studies suggest that although treatment of non-transformed mammary epithelial cells with IL-1β alone does not promote the acquisition of tumourigenic properties, IL-1β may act cooperatively with other oncogenic stimuli to promote these properties during tumour formation.